Hanmi Pharm. Co. Ltd. Reports Findings in Hypertension (The role of ambulatory blood pressure monitoring in enhancing medication adherence among patients with newly diagnosed hypertension: an analysis of the National Health Insurance cohort …): Cardiovascular Diseases and Conditions – Hypertension

2024 MAR 19 (NewsRx) -- By a News Reporter-Staff News Editor at Daily Asia Business -- New research on Cardiovascular Diseases and Conditions - Hypertension is the subject of a report. According to news reporting from Seoul, South Korea, by NewsRx journalists, research stated, “Improving adherence to antihypertensive medication (AHM) is a key challenge in hypertension management. This study aimed to assess the impact of ambulatory blood pressure monitoring (ABPM) on AHM adherence.”

The news correspondents obtained a quote from the research from Hanmi Pharm. Co. Ltd., “We utilized the Korean National Health Insurance Service database. Among patients newly diagnosed with hypertension who started AHM between July 2010 and December 2013, we compared clinical characteristics and adherence between 28,116 patients who underwent ABPM prior to starting AHM and 118,594 patients who did not undergo ABPM. Good adherence was defined as a proportion of days covered (PDC) of 0.8 or higher. The total study population was 146,710, with a mean age of 50.5 ± 6.4 years; 44.3% were female. Co-morbidities were noted in 4.2%. About a third of patients (33.1%) showed good adherence. The ABPM group had a notably higher PDC (total PDC: 0.64 ± 0.35 vs. 0.45 ± 0.39; P< 0.001), irrespective of the number of medications, dosing frequency, or prescription duration. After adjusting for significant clinical variables, ABPM was still closely linked with good adherence (odds ratio, 2.35; 95% confidence interval, 2.28-2.41; P< 0.001). In newly diagnosed hypertension, undergoing ABPM prior to AHM prescription appears to enhance adherence to AHM.”

According to the news reporters, the research concluded: “The exact mechanisms driving this association warrant further exploration.”

For more information on this research see: The role of ambulatory blood pressure monitoring in enhancing medication adherence among patients with newly diagnosed hypertension: an analysis of the National Health Insurance cohort database. Clinical Hypertension, 2024;30(1):6.

Our news journalists report that additional information may be obtained by contacting So-Jeong Park, Dept. of Data Science, Hanmi Pharm. Co. Ltd. Ltd., Seoul, South Korea. Additional authors for this research include Hack-Lyoung Kim, Yoon-Jong Bae, Sang Hyum Ihm, Jinho Shin and Kwang-Il Kim.

(Our reports deliver fact-based news of research and discoveries from around the world.)